What biomarkers or clinical or symptomatic metrics have you used to identify those patients who will clearly require biologic therapy as foundational approach?

What biomarkers or clinical or symptomatic metrics have you used to identify those patients who will clearly require biologic therapy as foundational approach?

What biomarkers or clinical or symptomatic metrics have you used to identify those patients who will clearly require biologic therapy as foundational approach?

CLICK HERE FOR CME CREDIT

Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Eric Ruderman, MD

Eric Ruderman, MD

Professor of Medicine
Division of Rheumatology
Northwestern University, Feinberg School of Medicine
Chicago, Illinois